The use of etanercept and other tumor necrosis factor-α blockers in infertility: It's time to get serious

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 1897-1899

  Wallace, Daniel J ^b   Weisman, Michael H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; CHROMATIN ANTIBODY; CORTICOSTEROID; CYTOKINE; ENOXAPARIN; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CASE REPORT; CLINICAL TRIAL; COMPLEMENT ACTIVATION; EDITORIAL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOTHERAPY; INFORMED CONSENT; INTERNET; LEUKOPENIA; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; REPRODUCTION; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SPONTANEOUS ABORTION;

ADULT; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RECEPTORS, TUMOR NECROSIS FACTOR; RISK ASSESSMENT; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042193645     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Sills ES, Perloe M, Tucker MJ, Kaplan CD, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anti-cytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001;46:366-8.
2. Wallace DJ, Druzin ML, Lahita RG. Clinical rheumatologic applications of reproductive immunology. Facts, fancy and fiction. Arthritis Rheum 1997;40:209-16.
3. Munno I, Chiechi LM, Lacerdra G, et al. Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia. Immunopharmacol Immunotoxicol 1999;21:551-64.
4. Murakami T, Okamura C, Matsuzaki S, et al. Prediction of pregnancy in infertile women with endometriosis. Gynecol Obstet Invest 2002;53 Suppl 1:26-32.
5. Bar J, Zosmer A, Hod M, Lahav J, Elder MG, Sullivan MH. Changes in the effects of interleukin-1 beta and tumor necrosis factor-alpha on platelet activation in early pregnancy. Platelets 2001; 8:453-5.
6. Daher S, Fonseca F, Ribeiro OG, Musatti CC, Gerbase-de Lima M. Tumor necrosis factor during pregnancy and at onset of labor and spontaneous abortion. Eur J Obstet Gynaecol Reprod Biol 1999; 83:77-9.
7. Westendorp RJG, van Dunne FM, Helmerhorst FM, Huizinga TWJ. Optimizing human fertility and survival. Nature Med 2001;7:873.
8. Ntrivalas EI, Kwak-Kim JY, Gilman-Sachs A, et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001;16:855-61.
9. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
10. Matsubayashi H, Hosaka T, Sugimaya Y, et al. Increased natural killer-cell activity is associated with infertile women. Am J Reprod Immunol 2001;46:318-22.
11. Morikawa M, Yamada H, Kato EH, et al. NK cell activity and subsets in women with a history of spontaneous abortion. Cause, number of abortions and subsequent pregnancy outcome. Gynecol Obstet Invest 2001;52:163-7.
12. Michimata T, Ogasawara MS, Tsuda H, et al. Distributions of endometrial NK cells, B cells, T cells and Th2/Th2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 2002;47:196-202.
13. Angles-Cano, Guillin MC. Antiphospholipid antibodies and the coagulation cascade. Rheum Dis Clin North Am 2001;27:573-86.
14. Merone PL, Raschi E, Testoni C, Tincani A, Balestrieri G. Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 2001;27:587-602.
15. Salmon JE, Girardi G, Holers VM. Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis 2002;61:Supp 2:46-50.
16. Horizon A, Furie R, Merrill J, et al. Results of a randomized, placebo-controlled, double-blind phase 1/2 clinical trial to assess the safety and tolerability of LJP 1082 in patients with antiphospholipid syndrome. Arthritis Rheum 2003 [Submitted for publication].